Yogesh Kolwadkar, MD
Adult Reconstructive Orthopaedic Surgery · Spencer, IANPI 1326327149
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $5,146 of the $8,253 with a category attached, or 62.3%. 9 manufacturers reported payments, led by Medinc Of Texas at 33.2% of the total. Reporting peaked in 2024 at $3,768 and has fallen 72.5% since, to $1,038 in 2025.
Across 65 payments — averaging $126.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medinc Of Texas$3K
- Arthrex$2K
- Stryker$1K
- Sequoia Surgical, Inc.$1K
- Zimmer Biomet$833
- Next Science LLC$313
- plus $235 from 3 others
What the payments were for
- Consulting fees$1081%
- Travel & lodging$5,14662%
- Food & beverage$1,91323%
- Education$1,08613%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medinc Of Texas | 11 | $2,741 |
| Arthrex | 18 | $1,761 |
| Stryker | 13 | $1,284 |
| Sequoia Surgical, Inc. | 1 | $1,086 |
| Zimmer Biomet | 13 | $833 |
| Next Science LLC | 3 | $313 |
| Orthalign Inc | 1 | $144 |
| Ferring Pharmaceuticals Inc. | 3 | $52 |
| Pacira Pharmaceuticals Incorporated | 2 | $39 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- BLUEPRINT PATIENT SPECIFIC INSTRUMENTATION$483
- Persona$325
- Taperloc$225
- Xperience$216
- BlastX$216
- SurgX$216
- MAKO$171
- ALPHAVENT$157
- INSPACE$157
- ORTHALIGN PLUS$144
How this compares
Too few adult reconstructive orthopaedic surgery providers in Iowato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Calcitonin-SalmonCalcitonin,salmon,synthetic | 22 | $1,269 |
| Celecoxib | 75 | $1,248 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 85 | $310 |
| Gabapentin | 74 | $281 |
| Doxycycline Monohydrate | 14 | $242 |
| Methocarbamol | 58 | $199 |
Paid to pharmacies, not to this prescriber.
Other adult reconstructive orthopaedic surgery in Spencer
- Omar AkhtarCedar Rapids$533K
- Nicolas NoiseuxIowa City$69K
- Sandeep MunjalCedar Rapids$33K
- Jeffrey NassifCedar Rapids$31K
- David DemikCedar Rapids$14K
- Todd PetersonClive$14K
- Christopher DickinsonWest Des Moines$9K
- Christopher NelsonWest Des Moines$5K
- Ryan PokorneyBettendorf$4K
- Benjamin BeecherDes Moines$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.